Proof of Usefulness Report

Etcembly Ltd.

Analysis completed on 2/7/2026

+557

Proof of Usefulness Score

Industry Mainstay

Etcembly Ltd is a verifiable, high-potential British biotech company (founded 2020) utilizing Generative AI (EMLy platform) to design T-cell receptor (TCR) immunotherapies. They have raised ~$15M (Series A), joined NVIDIA Inception, and developed a lead asset (ETC-101) in record time. However, the project submission itself was of extremely low quality, containing demonstrably false claims (e.g., 'most people have used my product', 'audience: everyone'). The score reflects the high intrinsic utility and technical innovation of the verifiable company, heavily penalized by low Quality Factors for the inaccurate and lazy submission data.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+22.5

Audience Reach Impact+5.0

Technical Innovation+14.25

Evidence Of Traction+10.63

Market Timing Relevance+9.0

Functional Completeness+0.5

Subtotal61.88 (Scale 0-100)

Usefulness Multiplierx0.90

Final ScoreNaN

Project Details

Project URL

etcembly.io

Description

Etcembly’s vision is to decode immune repertoires for health and disease. The TCR repertoire holds the answers to therapeutics and biomarker information, and Etcembly is assembling the world’s largest health and disease immune database, to revolutionise immunotherapy and personalised therapeutics across all patient groups, globally. We are pushing the frontiers to explore the intersection between immunology and machine learning.

Algorithm Insights

Market Position

Strong market validation with clear user adoption patterns

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline